Defining NASH As a Metabolic Disease: Can We Afford to Ignore It?

Drs Bugianesi and Gastaldelli discuss the rising global prevalence of NASH, screening with noninvasive tests, and emerging therapies. Credit available for this activity expires: [04/16/22] Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/949228?src=mkm_podcast_addon_949228